← Back to news

Serious Recall Issued for Bravo Capsule Devices Over Attachment Failures

Healthcare Purchasing News · September 16, 2026

The FDA has issued a Class I recall for Bravo CF esophageal pH-monitoring capsules due to attachment failures. This recall represents a critical safety issue for a medical device used in diagnostic procedures.

Read the full article on Healthcare Purchasing News